Management of severe COPD

被引：0
作者：
Schäfer H. [1 ]
机构：
[1] Innere Medizin — Pneumologie, Thorakale Onkologie, Infektiologie, Schlaf- und Beatmungsmedizin, Lungenzentrum Saar, SHG Kliniken Völklingen, Richardstraße 5–9, Völklingen
来源：
MMW - Fortschritte der Medizin | 2019年 / 161卷 / 10期
关键词：
COPD; non-pharmacologic treatment; pharmacologic treatment; severe chronic obstructive pulmonary disease;
D O I：
10.1007/s15006-019-0555-z
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：38 / 42
页数：4
相关论文
共 5 条
  • [1] Vogelmeier C.R., Buhl O., Burghuber Cp Criee S., Ewig J., Godnic-Cvar S., Hartl F., Herth P., Kardos K., Kenn D., Nowak K.F., Rabe M., Studnicka H., Watz T., Welte W., Windischworth H., Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD), Pneumologie, (2018)
  • [2] Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, (2019)
  • [3] Cazzola M., Matera M.G., Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis, ERJ, 52, (2018)
  • [4] Hajek P., Phillips-Waller A., Przulj D., Et al., A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy, N.Engl.J. Med., 380, pp. 629-637, (2019)
  • [5] van Geffen W.H., Slebos D.-J., Herth F.J., Et al., Surgical and endoscopic interventions that reduce lung volume for emphysema: A systemic review and meta-analysis, Lancet Respir Med, (2019)
1